Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P I Nikulnikov

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Klinichna Khirurhiia|October 1, 2015
[EXPERIENCE OF APPLICATION OF THE GENE INDUCTOR OF VASCULAR ENDOTHELIUM GROWTH FACTOR IN TREATMENT OF PATIENTS, SUFFERING ATHEROSCLEROTIC ISCHEMIA OF THE LOWER EXTREMITIES TISSUES]P I Nikulnikov
Klinichna Khirurhiia|October 3, 2018
[OBSERVATION OF SIMULTANT EXCISION OF RETROPERITONEAL SARCOMA, АОRTO-FEMORAL BIFURCATION АLLOSHUNTING AND A RIGHT-SIDED HEMICOLECTOMY]O Yu Usenko, A V Skums, P I Nikulnikov, et al.
Klinichna Khirurhiia|October 3, 2018
[THE EXPERTS CONSENSUS FOR ANTICOAGULANT THERAPY OF VENOUS THROMBOEMBOLISM IN 2016 YR. SIGNIFICANCE OF THE RIVAROXABAN INVESTIGATIONS PROGRAM FOR CHANGES OF APPROACHES, CONCERNING TREATMENT OF THE DEEP VEINS THROMBOSIS AND PULMONARY THROMBOEMBOLISM]S V Burnayeva, I I Vasilyeva, V K Gavrisyuk, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Klinichna Khirurhiia|October 1, 2015
[EXPERIENCE OF APPLICATION OF THE GENE INDUCTOR OF VASCULAR ENDOTHELIUM GROWTH FACTOR IN TREATMENT OF PATIENTS, SUFFERING ATHEROSCLEROTIC ISCHEMIA OF THE LOWER EXTREMITIES TISSUES]P I Nikulnikov
Klinichna Khirurhiia|October 3, 2018
[OBSERVATION OF SIMULTANT EXCISION OF RETROPERITONEAL SARCOMA, АОRTO-FEMORAL BIFURCATION АLLOSHUNTING AND A RIGHT-SIDED HEMICOLECTOMY]O Yu Usenko, A V Skums, P I Nikulnikov, et al.
Klinichna Khirurhiia|October 3, 2018
[THE EXPERTS CONSENSUS FOR ANTICOAGULANT THERAPY OF VENOUS THROMBOEMBOLISM IN 2016 YR. SIGNIFICANCE OF THE RIVAROXABAN INVESTIGATIONS PROGRAM FOR CHANGES OF APPROACHES, CONCERNING TREATMENT OF THE DEEP VEINS THROMBOSIS AND PULMONARY THROMBOEMBOLISM]S V Burnayeva, I I Vasilyeva, V K Gavrisyuk, et al.
Pageof 1